Clinical Study of SN301A Injection in the Treatment of Hepatocellular Carcinoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Clinical Study of SN301A Injection in the Treatment of Hepatocellular Carcinoma	Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm	Recruiting	Early phase 1	2024-11-25		NCT06652243

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Celest Therapeutics (Shanghai) Co., Ltd.	2
Senti Biosciences	2
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	141

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Shanghai General Hospital	Shanghai	China	59